Ileocaecal resection versus infliximab for ileal Crohn's disease: retrospective 10-year follow-up of the LIR!C trial.
The lancet. Gastroenterology & hepatology · Apr 1, 2026
What's New: Ileocaecal resection was associated with nearly three times the rate of 10-year therapy-free remission compared to infliximab in ileocaecal Crohn's disease.
Read more →